Qover Raises $12.9M for

Ditar

Empowering the eyewear industry with intelligent digital tools that make every purchase simple, personal, and inspiring. Ditar is a technology company redefining how people buy glasses. We design smart, user-friendly solutions that help opticians deliver modern, immersive experiences — combining precision, personalization, and performance. Our mission is to bridge human expertise with digital innovation, giving optical professionals the tools to work smarter, engage customers better, and grow faster. From face-scanning to smart recommendations and digital sales assistance, Ditar is shaping the future of eyewear — one experience at a time.

Borro

Borro offers a cashless deposit system to enable reuse at scale

AstriVax Therapeutics

Astrivax Therapeutics (Astrivax) is a clinical-stage biopharmaceutical company on a mission to end virus-driven cancer, the second leading preventable cause of cancer after smoking. Its clinically validated Launch-iT platform generates durable, antigen-specific T-cell responses that clear virus-infected cells, supported by a scalable, tech-transfer–ready manufacturing process. Astrivax’s lead program targets human papillomavirus 16 (HPV16), a leading cause of virus-driven cancers, including cervical cancer and head and neck cancer. The company is advancing its platform toward clinical proof-of-concept for persistent HPV infections and plans to expand across additional HPV-driven cancers. Beyond oncology, Astrivax is exploring applications in autoimmune diseases where viral infections are increasingly recognized as drivers of disease.

ReVision Implant

ReVision Implant is developing the world's first prosthesis that can restore useful vision to blind people. We are using implants with thousands of microelectrodes and advanced stimulation algorithms to directly transmit video images to the visual cortex of the brain.

D-CRBN

D-CRBN recycles CO2 for industrials through our patented CCU plasma technology. We use plasma to convert CO2 emissions to useful chemical building blocks. Our plasma process splits CO2 molecules into their original building blocks to make e-fuels, chemicals, or polymers to ultimately achieve a circular and more sustainable economy. Battling global warming will be the toughest environmental challenge that our society has ever faced. We have set our objectives to help reduce CO2 emissions, reaching a carbon-neutral society by 2050. Launch your CO2 recycling initiative at your plant, go net-zero and join us to Sparc* the new industrial revolution.